Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page
- Check2 days agoChange DetectedMelanoma is added as a related topic and MedlinePlus Genetics is linked. The page revision is updated from v3.3.3 to v3.3.4.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a footer line: Revision: v3.3.3; several footer links were removed, including HHS Vulnerability Disclosure, Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check31 days agoChange DetectedMelanoma and MedlinePlus Genetics are added as related topics on the page to improve navigation and context without altering the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedDeleted items: the 'Melanoma' entry, the 'related topics:' header, and the 'MedlinePlus Genetics' link from the related information section; these are navigational/background references and do not alter the main study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedThe change updates the page revision from v3.3.1 to v3.3.2 and does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0, a minor site maintenance update.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.